J Knee Surg 2022; 35(06): 668-675
DOI: 10.1055/s-0040-1716507
Original Article

Distinguishing Periprosthetic Crystalline Arthropathy from Infection in Total Knee Arthroplasty: A Systematic Review

Alexander T. Bradley
1   Orthopaedic Surgery Department, Department 4B, University of Chicago, Chicago, Illinois
,
1   Orthopaedic Surgery Department, Department 4B, University of Chicago, Chicago, Illinois
,
Ye Lin
2   University of Chicago Pritzker School of Medicine, Chicago, Illinois
,
Peter Sculco
3   Department of Orthopaedic Surgery, Hospital for Special Surgery, New York City, New York
,
Tessa Balach
1   Orthopaedic Surgery Department, Department 4B, University of Chicago, Chicago, Illinois
,
David C. Landy
3   Department of Orthopaedic Surgery, Hospital for Special Surgery, New York City, New York
› Author Affiliations

Abstract

Distinguishing periprosthetic crystalline arthropathy from periprosthetic joint infection (PJI) remains a diagnostic challenge as both symptom presentation and diagnostic tests overlap. Accurate differentiation is important as treatment plans vary significantly. We sought to systematically review all cases of total knee arthroplasty (TKA) periprosthetic crystalline arthropathy reported in the literature and summarize clinical, diagnostic, and operative findings in the context of guidelines for diagnosing PJI. The goal of this systematic review is to determine the amount of diagnostic overlap and to identify best practices for differentiating between these two diagnoses. MEDLINE and Google Scholar were searched to identify cases of crystalline arthropathy following TKA. Case reports were reviewed for patient characteristics, clinical symptoms, physical exam, laboratory results, and treatment outcomes. These findings were summarized across patients and dichotomized based on current thresholds for diagnosing PJI according to Musculoskeletal Infection Society criteria. Twenty-six articles were identified which included 42 cases of periprosthetic crystalline arthropathy (17 gout, 16 pseudogout, one both, and eight not specified). Of these cases, 25 presented over 1 year after their index arthroplasty and 15 had no prior history of crystalline arthropathy. Only six cases had a superimposed infection based on aspiration or intraoperative cultures. For cases without a culture-positive infection, several diagnostic tests overlap with PJI thresholds: 95% of patients had C-reactive protein greater than 1 mg/dL, 76% had an erythrocyte sedimentation rate greater than 30 mm/hour, 91% had a synovial white blood cell greater than 3,000 cells, and 76% had a synovial polymorphonuclear cells percent greater than 80%. Patients without co-infection were managed with non-steroidal anti-inflammatory drugs, colchicine, allopurinol, steroids, or a combination of these treatments and most had complete resolution of symptoms within 1 week. Commonly used markers of PJI fail to reliably distinguish periprosthetic crystalline arthropathy from infection. Though clinical judgement and consideration of the implications of delayed treatment for acute PJI remain paramount, in the setting of synovial crystals, surgeons may wish to consider this alternate etiology as the source of the patient's clinical symptoms.



Publication History

Received: 27 April 2020

Accepted: 29 July 2020

Article published online:
17 September 2020

© 2020. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Phillips JE, Crane TP, Noy M, Elliott TS, Grimer RJ. The incidence of deep prosthetic infections in a specialist orthopaedic hospital: a 15-year prospective survey. J Bone Joint Surg Br 2006; 88 (07) 943-948
  • 2 Kurtz SM, Ong KL, Lau E, Bozic KJ, Berry D, Parvizi J. Prosthetic joint infection risk after TKA in the Medicare population. Clin Orthop Relat Res 2010; 468 (01) 52-56
  • 3 Pitta M, Esposito CI, Li Z, Lee YY, Wright TM, Padgett DE. Failure after modern total knee arthroplasty: a prospective study of 18,065 knees. J Arthroplasty 2018; 33 (02) 407-414
  • 4 Sharkey PF, Lichstein PM, Shen C, Tokarski AT, Parvizi J. Why are total knee arthroplasties failing today--has anything changed after 10 years?. J Arthroplasty 2014; 29 (09) 1774-1778
  • 5 Bozic KJ, Kurtz SM, Lau E. et al The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res 2010; 468 (01) 45-51
  • 6 O'Toole P, Maltenfort MG, Chen AF, Parvizi J, O'Toole P, Maltenfort MG, Chen AF, Parvizi J. Projected increase in periprosthetic joint infections secondary to rise in diabetes and obesity. J Arthroplasty 2016; 31 (01) 7-10
  • 7 Sloan M, Premkumar A, Sheth NP. Projected volume of primary total joint arthroplasty in the U.S., 2014 to 2030. J Bone Joint Surg Am 2018; 100 (17) 1455-1460
  • 8 Parvizi J, Zmistowski B, Berbari EF. et al New definition for periprosthetic joint infection: from the Workgroup of the Musculoskeletal Infection Society. Clin Orthop Relat Res 2011; 469 (11) 2992-2994
  • 9 Parvizi J, Fassihi SC, Enayatollahi MA. Diagnosis of periprosthetic joint infection following hip and knee arthroplasty. Orthop Clin North Am 2016; 47 (03) 505-515
  • 10 CDC/NHSN surveillance definitions for specific types of infections. Available at: Accessed January 2019 https://www.cdc.gov/nhsn/PDFs/pscManual/17pscNosInfDef_current.pdf
  • 11 Kelly MP, Darrith B, Hannon CP, Nam D, Courtney PM, Della Valle CJ. Synovial fluid alpha-defensin is an adjunctive tool in the equivocal diagnosis of periprosthetic joint infection. J Arthroplasty 2018; 33 (11) 3537-3540
  • 12 Pannu TS, Villa JM, Riesgo AM, Patel PD, Barsoum WK, Higuera-Rueda CA. Serum D-dimer in the diagnosis of periprosthetic knee infection: where are we today?. J Knee Surg 2020; 33 (02) 106-110
  • 13 Wang C, Wang Q, Li R. et al LTF, PRTN3, and MNDA in synovial fluid as promising biomarkers for periprosthetic joint infection: identification by quadrupole orbital-trap mass spectrometry. J Bone Joint Surg Am 2019; 101 (24) 2226-2234
  • 14 Kheir MM, Tan TL, Shohat N, Foltz C, Parvizi J. Routine diagnostic tests for periprosthetic joint infection demonstrate a high false-negative rate and are influenced by the infecting organism. J Bone Joint Surg Am 2018; 100 (23) 2057-2065
  • 15 Chen-Xu M, Yokose C, Rai SK, Pillinger MH, Choi HK. Contemporary prevalence of gout and hyperuricemia in the United States and decadal trends: the national health and nutrition examination survey, 2007–2016. Arthritis Rheumatol 2019; 71 (06) 991-999
  • 16 Arthritis by the Numbers. Vol 2. Arthritis Foundation. 2018 . Available at: Accessed 2018 https://www.arthritis.org/Documents/Sections/About-Arthritis/arthritis-facts-stats-figures.pdf
  • 17 Kleiber Balderrama C, Rosenthal AK, Lans D, Singh JA, Bartels CM. Calcium pyrophosphate deposition disease and associated medical co-morbidities: a national cross-sectional study of U.S. veterans. Arthritis Care Res (Hoboken) 2017; 69 (09) 1400-1406
  • 18 Macmullan P, McCarthy G. Treatment and management of pseudogout: insights for the clinician. Ther Adv Musculoskelet Dis 2012; 4 (02) 121-131
  • 19 Richardson SS, Kahlenberg CA, Goodman SM. et al Inflammatory arthritis is a risk factor for multiple complications after total hip arthroplasty: a population-based comparative study of 68,348 patients. J Arthroplasty 2019; 34 (06) 1150-1154.e2
  • 20 Williamson SC, Roger DJ, Petrera P, Glockner F. Acute gouty arthropathy after total knee arthroplasty. A case report. J Bone Joint Surg Am 1994; 76 (01) 126-128
  • 21 Carter JL, Endres NK, Halsey DA. Bilateral acute calcium pyrophosphate crystal arthritis after bilateral total knee arthroplasty. JBJS Case Connect 2012; 2 (04) e59
  • 22 Yahia SA, Zeller V, Desplaces N. et al Crystal-induced arthritis after arthroplasty: 7 cases. Joint Bone Spine 2016; 83 (05) 559-562
  • 23 Moher D, Liberati A, Tetzlaff J, Altman DG. PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6 (07) e1000097
  • 24 Gardner J, Gioe TJ, Tatman P. Can this prosthesis be saved?: implant salvage attempts in infected primary TKA. Clin Orthop Relat Res 2011; 469 (04) 970-976
  • 25 Parvizi J, Tan TL, Goswami K. et al CHen AF, Shohat N. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty 2018; 33 (05) 1309-1314.e2
  • 26 Romanò CL, Manzi G, Logoluso N, Romanò D. Value of debridement and irrigation for the treatment of peri-prosthetic infections. A systematic review. HIP International 2012; 22 (Suppl. 08) 19-24
  • 27 Byren I, Bejon P, Atkins BL. et al One hundred and twelve infected arthroplasties treated with ‘DAIR’ (debridement, antibiotics and implant retention): antibiotic duration and outcome. J Antimicrob Chemother 2009; 63 (06) 1264-1271
  • 28 Masters JP, Smith NA, Foguet P, Reed M, Parsons H, Sprowson AP. A systematic review of the evidence for single stage and two stage revision of infected knee replacement. BMC Musculoskelet Disord 2013; 14 (01) 222
  • 29 Lee YS, Chen AF. Chen and AF. Two-stage reimplantation in infected total knee arthroplasty. Knee Surg Relat Res 2018; 30 (02) 107-114
  • 30 Wyatt MC, Beswick AD, Kunutsor SK, Wilson MJ, Whitehouse MR, Blom AW. The alpha-defensin immunoassay and leukocyte esterase colorimetric strip test for the diagnosis of periprosthetic infection: a systematic review and meta-analysis. J Bone Joint Surg Am 2016; 98 (12) 992-1000
  • 31 Partridge DG, Gordon A, Townsend R. False-positive synovial fluid alpha-defensin test in a patient with acute gout affecting a prosthetic knee. Eur J Orthop Surg Traumatol 2017; 27 (04) 549-551
  • 32 Tarabichi M, Shohat N, Goswami K. et al Diagnosis of periprosthetic joint infection: the potential of next-generation sequencing. J Bone Joint Surg Am 2018; 100 (02) 147-154
  • 33 Kurtz SM, Lau E, Watson H, Schmier JK, Parvizi J. Economic burden of periprosthetic joint infection in the United States. J Arthroplasty 2012; 27 (08) 61-5.e1
  • 34 Bhandari M, Smith J, Miller LE, Block JE. Clinical and economic burden of revision knee arthroplasty. Clin Med Insights Arthritis Musculoskelet Disord 2012; 5: 89-94
  • 35 Garrido-Gómez J, Arrabal-Polo MA, Girón-Prieto MS, Cabello-Salas J, Torres-Barroso J, Parra-Ruiz J. Descriptive analysis of the economic costs of periprosthetic joint infection of the knee for the public health system of Andalusia. J Arthroplasty 2013; 28 (07) 1057-1060
  • 36 Haddad FS, Ngu A, Negus JJ. Prosthetic joint infections and cost analysis?. In: Drago L. ed. A Modern Approach to Biofilm-Related Orthopaedic Implant Infections: Advances in Microbiology, Infectious Diseases and Public Health Volume 5. Advances in Experimental Medicine and Biology. Cham: Springer International Publishing; 2017: 93-100
  • 37 Kallala RF, Vanhegan IS, Ibrahim MS, Sarmah S, Haddad FS. Financial analysis of revision knee surgery based on NHS tariffs and hospital costs: does it pay to provide a revision service?. Bone Joint J 2015; 97-B (02) 197-201
  • 38 Odum SM, Fehring TK, Lombardi AV. Periprosthetic Infection Consortium. et al Irrigation and debridement for periprosthetic infections: does the organism matter?. J Arthroplasty 2011; 26 (06) 114-118
  • 39 Charette RS, Melnic CM. Two-stage revision arthroplasty for the treatment of prosthetic joint infection. Curr Rev Musculoskelet Med 2018; 11 (03) 332-340
  • 40 Rosenthal AK, Ryan LM. Calcium pyrophosphate deposition disease. N Engl J Med 2016; 374 (26) 2575-2584
  • 41 Gout NT. N Engl J Med 2011; 364 (05) 443-452
  • 42 Kooner SS, Clark M. The effect of synovectomy in total knee arthroplasty for primary osteoarthritis: a meta-analysis. J Knee Surg 2017; 30 (04) 289-296